Choto Emilia T, Mduluza Takafira, Mutapi Francisca, Chimbari Moses J
University of KwaZulu Natal, School of Nursing and Public Health, 6 College of Health Sciences, Howard College, 269 Mazisi Kunene Road, Berea, Durban, 4041,7 South Africa.
University of Zimbabwe, Biochemistry Department, P.O. Box MP 167, Mount Pleasant, Harare, Zimbabwe.
Infect Agent Cancer. 2020 Oct 6;15:59. doi: 10.1186/s13027-020-00327-2. eCollection 2020.
Prostatic male genital schistosomiasis and prostate cancer co-existence cases are uncommon however, some studies have indicated that schistosomiasis may trigger development of prostate cancer regardless of age. Schistosomiasis is a public health problem in sub-Saharan Africa and may account for some undocumented cases of schistosomiasis prostatic cancer in schistosome endemic rural communities. It is against this background that we investigated the association between schistosomiasis and risk of prostate cancer development in residents of Murehwa Community, a schistosomiasis endemic area.
We conducted a cross sectional study involving 366 men residing in Murehwa District, Zimbabwe. and infection was diagnosed using urine filtration and Kato Katz techniques, respectively. Haematuria was detected using urinalysis reagent strip test. A structured questionnaire was used to obtain history of schistosomiasis infection among study participants. Risk of prostate cancer development was assessed by measuring prostate-specific antigen levels in serum using the ELISA.
Prevalence of and infection was 12.3% and 1.4%, respectively. Individuals with schistosomiasis had higher prostate-specific antigen levels (mean 1.208 ± SD 1.557 ng/mL) compared to those without schistosomiasis (mean 0.7721 ± SD 1.173 ng/mL; < 0.05). Older individuals > 50 years had higher prostate specific antigen levels (mean 0.7212 ± SD 1.313 ng/mL) compared to individuals < 50 years old (mean 0.4159 ± SD 0.8622 ng/mL; < 0.05). Prostate-specific antigen levels log (mean 0.2584 ± SD 0.2128 ng/mL) and were associated to infection intensity log (mean 1.121 ± SD 0.5371 eggs/10 mL), r(s) = - 0.3225, < 0.05. There was a correlation between prostate-specific antigen levels log (mean 0.2246 ± SD 0.1858 ng/mL) and infection intensity log (mean 1.169 ± SD 0.5568 eggs/10 mL) among participants with a history of schistosomiasis infection (r(s) = - 0.3520; < 0.05). There was no correlation between prostate-specific antigen levels of > 4 ng/mL (mean 5.324 ± SD1.568 ng/mL) and schistosome eggs log (mean 1.057 ± SD 0.6730 eggs/10 mL; > 0.05).
Urogenital schistosome infections and history of schistosome infections were associated with prostate specific antigen levels, an indicator for risk of prostate cancer. Therefore, schistosome egg burden was associated with the risk of prostate cancer development in adult males residing in Murehwa District, Zimbabwe.
前列腺男性生殖系统血吸虫病与前列腺癌并存的病例并不常见,然而,一些研究表明,无论年龄大小,血吸虫病可能会引发前列腺癌的发生。血吸虫病是撒哈拉以南非洲的一个公共卫生问题,在血吸虫病流行的农村社区,可能存在一些未记录的前列腺癌血吸虫病病例。正是在这样的背景下,我们调查了血吸虫病流行地区穆雷瓦社区居民中血吸虫病与前列腺癌发生风险之间的关联。
我们进行了一项横断面研究,涉及居住在津巴布韦穆雷瓦区的366名男性。分别使用尿液过滤法和加藤厚涂片法诊断血吸虫感染。使用尿液分析试纸条检测血尿。使用结构化问卷获取研究参与者的血吸虫病感染史。通过酶联免疫吸附测定法测量血清中的前列腺特异性抗原水平,评估前列腺癌发生的风险。
血吸虫感染和埃及血吸虫感染的患病率分别为12.3%和1.4%。与未感染血吸虫病的人相比,感染血吸虫病的人前列腺特异性抗原水平更高(平均值1.208±标准差1.557 ng/mL)(平均值0.7721±标准差1.173 ng/mL;P<0.05)。50岁以上的老年人前列腺特异性抗原水平(平均值0.7212±标准差1.313 ng/mL)高于50岁以下的人(平均值0.4159±标准差0.8622 ng/mL;P<0.05)。前列腺特异性抗原水平对数(平均值0.2584±标准差0.2128 ng/mL)与埃及血吸虫感染强度对数(平均值1.121±标准差0.5371个虫卵/10 mL)相关,r(s)= - 0.3225,P<0.05。在有血吸虫病感染史的参与者中,前列腺特异性抗原水平对数(平均值0.2246±标准差0.1858 ng/mL)与曼氏血吸虫感染强度对数(平均值1.169±标准差0.5568个虫卵/10 mL)之间存在相关性(r(s)= - 0.3520;P<0.05)。前列腺特异性抗原水平>4 ng/mL(平均值5.324±标准差1.568 ng/mL)与血吸虫虫卵对数(平均值1.057±标准差0.6730个虫卵/10 mL;P>0.05)之间无相关性。
泌尿生殖系统血吸虫感染和血吸虫感染史与前列腺特异性抗原水平相关,前列腺特异性抗原水平是前列腺癌风险的一个指标。因此,血吸虫虫卵负荷与居住在津巴布韦穆雷瓦区成年男性前列腺癌发生风险相关。